Activity of cabazitaxel in patients with metastatic castration-resistant prostate cancer after treatment with single or dual regimens of novel androgen receptor-targeting agents
Crossref DOI link: https://doi.org/10.1007/s12032-017-1024-0
Published Online: 2017-08-17
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bando, Yukari
Hinata, Nobuyuki http://orcid.org/0000-0001-7014-6812
Terakawa, Tomoaki
Furukawa, Junya
Harada, Ken-ichi
Nakano, Yuzo
Fujisawa, Masato
License valid from 2017-08-17